Dr Vance Spence
Co-founder of ME Research UK:
"I have personally known Tom Kindlon for over 20 years and I endorse his nomination for an honorary degree at Trinity College Dublin. The award would be a recognition of his outstanding contribution to people suffering from myalgic encephalomyelitis (ME), indeed, the illness has severely impacted Tom's own life, contracting ME while studying for a degree in mathematics at this very university. Tom has provided unwavering support to many individuals with ME within Ireland and indeed to a much wider global population of sufferers. His dedication is rooted in a genuine compassion for people who, like himself, have to cope with the unique struggles that their illness presents.
Tom has also made connections with many academics and researchers across the world. He positioned himself between academics and an online community of patients, assisting with research fundraising and also providing an invaluable service by interpreting and disseminating complex research data back to a population of people desperate for new developments. I was one of the researchers who benefited from Tom's generosity; I struggled to get research grants for what is, and remains, a contested illness but I was eternally grateful to Tom and others for their fund-raising efforts allowing me to complete several projects and to publish in peer-reviewed journals.
I firmly believe that Tom Kindlon is a deserving candidate for an honorary award. His contributions have made a real difference for an incalculable number of ME patients and, hopefully, he has set an example for others to follow. Recognising Tom's achievements would not only validate his own efforts but act as a source of inspiration for others who feel similarly disenfranchised.
Thank you for considering this nomination. I am confident that by honouring Tom the university will not only celebrate his unwavering commitment to improving the lives of an especially vulnerable disabled group but also shed light on a greatly misunderstood and enigmatic condition."
Dr Vance Spence
Co-founder of ME Research UK